认知行为疗法对慢性心力衰竭并焦虑抑郁患者心理状态、睡眠状况及心功能的影响研究

doi:10.20047/j.issn1673-7210.2022.31.23

Abstract
Figure/Table
References (25)
Related Citation (15)

Download: PDF (0 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To study the effects of cognitive behavioral therapy on mental state, sleep status, and cardiac function in patients with chronic heart failure complicated with anxiety and depression. Methods A total of 160 patients with chronic heart failure complicated with anxiety and depression admitted in Qinhuangdao Jungong Hospital of Hebei Province from January 2020 to December 2021 were selected, they were divided into control group and observation group by random number table method, with 80 patients in each group. Both groups received symptomatic drug therapy and Sakobactri Valsartan Sodium Tablets, the control group received conventional psychological intervention on this basis, and the observation group received cognitive behavioral therapy. The psychological state, sleep quality, and cardiac function indexes before and after intervention were compared between the two groups. Results After intervention, the scores of Hamilton anxiety scale, Hamilton depression scale, and Pittsburgh sleep quality index in two groups were lower than those before intervention, and observation group was lower than control group (P ＜ 0.05). After intervention, left ventricular end-diastolic dimension and left ventricular end-systolic diameter in two groups were lower than those before intervention, and observation group was lower than control group (P ＜ 0.05); left ventricular ejection fraction in two groups were higher than those before intervention, and observation group was higher than control group (P ＜ 0.05). After intervention, brain natriuretic peptide, cardiac troponin I, and creatine kinase isoenzyme MB in two groups were lower than those before intervention, and observation group was lower than control group (P ＜ 0.05). Conclusion Based on the drug control, the comprehensive management mode combined with cognitive behavioral therapy for patients with chronic heart failure complicated with and anxiety and depression during rehabilitation has positive effects on patients’ quality of life, myocardial indicators, and disease control, which is worth promoting.

Key words： Sakurbactral Valsartan Sodium Tablets Cognitive behavior Chronic heart failure Anxiety and depression Sleep quality Cardiac function

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	WANG Jiawei1 WU Yechen2 ZHANG Yanping1 YANG Fan1 WANG Chunmei1 SUN Bingyan1 ZHANG Zheng2 ZHAO Yingyu2

Cite this article:

WANG Jiawei1 WU Yechen2 ZHANG Yanping1 YANG Fan1 WANG Chunmei1 SUN Bingyan1 ZHANG Zheng2 ZHAO Yingyu2. Effects of cognitive behavioral therapy on mental state, sleep status, and cardiac function in patients with chronic heart failure complicated with anxiety and depression[J]. 中国医药导报, 2022, 19(31): 100-103.

URL:

https://www.yiyaodaobao.com.cn/EN/10.20047/j.issn1673-7210.2022.31.23 OR https://www.yiyaodaobao.com.cn/EN/Y2022/V19/I31/100

[1] 张亚玲，李明，谭刚，等.沙库巴曲缬沙坦钠片联合百令胶囊治疗慢性左心衰竭合并肾功能不全的临床观察[J].中国药房，2021，32（6）：720-724.
[2] 陈啸，张嘉玮，笪月芳.有氧运动联合认知行为疗法对慢性心力衰竭患者认知功能损伤的改善作用[J].现代医学，2019，47（2）：141-145.
[3] Bredy C，Ministeri M，Kempny A，et al. New York Heart Association（NYHA）classification in adults with congenital heart disease：relation to objective measures of exercise and outcome [J]. Eur Heart J Qual Care Clin Outcomes，2018，4（1）：51-58.
[4] Dunstan DA，Scott N. Norms for Zung’s Self-rating Anxiety Scale [J]. BMC Psychiatry，2020，20（1）：90.
[5] 罗烨，欧阳昆富，陈延军.沙库巴曲缬沙坦对射血分数降低心力衰竭患者超声、生化、临床方面的短期疗效[J].分子影像学杂志，2020，43（2）：291-295.
[6] 王展，石玉芝，王安心，等.中国缺血性脑卒中急性期汉密尔顿抑郁量表评分的性别差异[C]//2015北京医学会神经病学学术年会论文集，2015：306.
[7] 杨潇，李涛，马小红.未治疗重性抑郁症患者汉密尔顿抑郁量表各因子分及大脑结构异常的性别差异[C]//中国神经科学学会精神病学基础与临床分会第十三届学术年会论文集，2016：305.
[8] 夏静，于宏梅，徐懿，等.百令胶囊联合美托洛尔对冠心病伴心力衰竭患者炎症、氧化应激水平及血管内皮功能的影响[J].河北医药，2020，18（5）：659-663.
[9] 冯立，彭博文，高智.百令胶囊联合α-酮酸片对慢性肾衰竭患者肾功能和微炎症状态的影响[J].现代中西医结合杂志，2019，26（30）：3366-3369.
[10] 金子安，陈阳.沙库巴曲缬沙坦治疗射血分数下降的慢性心力衰竭合并肾功能不全的临床疗效研究[J].实用心脑肺血管病杂志，2020，28（5）：91-95.
[11] 于艳丽.慢性心衰经沙库巴曲缬沙坦钠片治疗及对心功能指标的影响[J].海峡药学，2021，33（3）：347-349.
[12] 周华，王丽萍.沙库巴曲缬沙坦钠片治疗左心室射血分数保留心力衰竭的疗效分析[J].现代实用医学，2020， 32（5）：484-485.
[13] 郑剑琴，王晓光.百令胶囊联合复方α-酮酸片治疗慢性肾衰竭临床分析[J].实用中医药杂志，2018，39（10）：1230-1231.
[14] 杜小琴，姜文锡，赵静.沙库巴曲缬沙坦钠片治疗慢性左心衰竭合并肾衰竭的临床疗效及其对预后的影响[J].中国医学前沿杂志（电子版），2019，11（10）：157-161.
[15] 董萌.沙库巴曲缬沙坦钠治疗老年慢性心力衰竭合并肾功能不全患者的临床观察[J].中国中西医结合急救杂志，2020，27（1）：84-87.
[16] 连惠英.积极心理联合团队认知行为干预对广泛性焦虑症患者的影响[J].中外医学研究，2022，20（10）：154-156.
[17] 范秋瑾，高勤，王佳慧.人际关系-社会节律与认知行为治疗在抑郁症患者中的临床应用价值[J].中国医药导报，2021，18（11）：121-124.
[18] 王莹澄，邹露婷，毛芳，等.认知行为干预在冠心病患者护理中的应用效果[J].中国现代医生，2020，58（1）：181-183.
[19] 王毅，杨征.托伐普坦和沙库巴曲缬沙坦钠片对慢性心力衰竭患者心功能及血清钠水平的影响研究[J].陕西医学杂志，2019，48（4）：470-472.
[20] 黄琨，马威，郑川燕，等.托伐普坦治疗老年难治性心力衰竭的效果及对神经内分泌因子的影响[J].中国老年学杂志，2018，38（5）：1025-1028.
[21] 黄兆琦，黄淑玲，袁慧萍，等.个性化康复运动对慢性心力衰竭患者的干预效果和安全性[J].中国老年学杂志，2019，34（20）：4892-4895.
[22] 段洋洋，闫小琼，陈兴宛，等.慢性心力衰竭患者血清Gal-3、BNP水平对沙库巴曲缬沙坦钠片疗效的影响[J].河南医学研究，2021，30（34）：6433-6436.
[23] 徐慧，文薏.沙库巴曲缬沙坦钠片对老年慢性心力衰竭患者心功能以及BNP的影响分析[J].中国现代药物应用，2021，15（17）：194-196.
[24] 王智刚，王小妮，惠玲玲，等.沙库巴曲缬沙坦钠片联合重组人脑利钠肽对急性心肌梗死合并心力衰竭患者NT-proBNP及心功能的影响[J].临床医学研究与实践，2021，6（3）：58-60.
[25] 吴宇.不同药物在射血分数降低的心力衰竭患者治疗中的效果分析及对心室重塑指标的影响[J].中国医学创新，2021，18（22）：56-61.